MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-22-2025
Intuitive Surgical Accounts Receivables 2011-2025 | ISRG
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Intuitive Surgical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.23 B | 1.13 B | 942 M | 783 M | 646 M | 645 M | 682 M | 512 M | 430 M | 394 M | 315 M | 301 M | 370 M | 298 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.23 B | 298 M | 620 M |
Quarterly Accounts Receivables Intuitive Surgical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.26 B | 1.27 B | 1.22 B | 1.23 B | 1.15 B | 1.11 B | 1.13 B | 1.13 B | 963 M | - | 925 M | 942 M | 850 M | - | 906 M | 783 M | 695 M | 700 M | 654 M | 646 M | 646 M | 646 M | 646 M | 645 M | 645 M | 645 M | 645 M | 682 M | 682 M | 682 M | 682 M | 508 M | 508 M | 508 M | 508 M | 430 M | 430 M | 430 M | 430 M | 394 M | 394 M | 394 M | 394 M | 315 M | 315 M | 315 M | 315 M | 301 M | 301 M | 301 M | 301 M | 370 M | 370 M | 370 M | 370 M | 298 M | 298 M | 298 M | 298 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 B | 298 M | 619 M |
Accounts Receivables of other stocks in the Medical instruments industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
1.54 B | $ 19.12 | -1.34 % | $ 9.75 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
2.99 B | $ 194.81 | -0.77 % | $ 56 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
7.24 M | $ 5.51 | -0.88 % | $ 111 M | USA |
 |
Harvard Bioscience
HBIO
|
16.1 M | $ 0.67 | -4.31 % | $ 28.4 M | USA |
 |
Repro Med Systems
KRMD
|
4.05 M | $ 6.08 | -2.46 % | $ 277 M | USA |
 |
LeMaitre Vascular
LMAT
|
30.1 M | $ 83.04 | -0.88 % | $ 1.86 B | USA |
 |
iRhythm Technologies
IRTC
|
79.9 M | $ 177.72 | 0.63 % | $ 5.54 B | USA |
 |
Masimo Corporation
MASI
|
141 M | $ 131.34 | -1.07 % | $ 7 B | USA |
 |
ICU Medical
ICUI
|
183 M | $ 146.95 | -0.62 % | $ 3.58 B | USA |
 |
AtriCure
ATRC
|
60.3 M | $ 40.71 | 0.94 % | $ 1.91 B | USA |
 |
Atrion Corporation
ATRI
|
23 K | - | - | $ 810 M | USA |
 |
Merit Medical Systems
MMSI
|
190 M | $ 88.28 | 1.02 % | $ 5.14 B | USA |
 |
electroCore
ECOR
|
717 K | $ 4.86 | -1.82 % | $ 26.8 K | USA |
 |
Isoray
ISR
|
116 K | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
42.9 M | $ 12.89 | -1.6 % | $ 527 M | USA |
 |
The Cooper Companies
COO
|
829 M | $ 82.05 | -0.69 % | $ 16.3 B | USA |
 |
OraSure Technologies
OSUR
|
23.8 M | $ 2.44 | 0.83 % | $ 182 M | USA |
 |
Glaukos Corporation
GKOS
|
39.8 M | $ 115.84 | -0.32 % | $ 5.61 B | USA |
 |
Haemonetics Corporation
HAE
|
203 M | $ 80.12 | -0.2 % | $ 4.03 B | USA |
 |
InfuSystem Holdings
INFU
|
16.9 M | $ 8.77 | -2.12 % | $ 181 M | USA |
 |
ResMed
RMD
|
576 M | $ 243.57 | -0.49 % | $ 35.6 B | USA |
 |
Microbot Medical
MBOT
|
159 K | $ 2.08 | -3.26 % | $ 21.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
475 K | $ 0.29 | 0.07 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
1.5 M | $ 5.0 | 1.32 % | $ 51.9 M | USA |
 |
NeuroMetrix
NURO
|
193 K | - | 5.05 % | $ 9.02 M | USA |
 |
STERIS plc
STE
|
1.04 B | $ 256.68 | 0.49 % | $ 25.3 B | USA |
 |
Envista Holdings Corporation
NVST
|
363 M | $ 21.77 | -1.0 % | $ 3.75 B | USA |
 |
Predictive Oncology
POAI
|
746 K | - | - | $ 32.4 M | USA |
 |
Stereotaxis
STXS
|
3.82 M | $ 2.29 | -6.91 % | $ 185 M | USA |
 |
Utah Medical Products
UTMD
|
3.39 M | $ 56.92 | 0.29 % | $ 207 M | USA |
 |
Pro-Dex
PDEX
|
16.4 M | $ 38.49 | -2.43 % | $ 127 M | USA |
 |
Pulse Biosciences
PLSE
|
61 K | $ 14.09 | -2.15 % | $ 677 M | USA |
 |
Repligen Corporation
RGEN
|
124 M | $ 165.5 | -0.43 % | $ 9.22 M | USA |
 |
BioLife Solutions
BLFS
|
9.17 M | $ 24.92 | 0.06 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
7.79 M | $ 0.8 | -4.39 % | $ 23.9 M | USA |
 |
STAAR Surgical Company
STAA
|
77.9 M | $ 23.66 | 1.31 % | $ 1.16 B | USA |
 |
Teleflex Incorporated
TFX
|
459 M | $ 122.31 | -0.37 % | $ 5.73 B | USA |
 |
West Pharmaceutical Services
WST
|
552 M | $ 274.17 | -0.05 % | $ 20 B | USA |